Background The proportion of people who are diagnosed late is a key metric to measure the
public health response to HIV. But this percentage remains stubbornly high in nearly every …

Objectives Late treatment initiation threatens the clinical and public health benefits of
antiretroviral therapy (ART). Quantitative synthesizes of the existing evidence related to this …

Systematic HIV program evaluation requires looking at all steps of the HIV cascade of care,
from diagnosis to treatment outcomes. Our study was carried out to assess the treatment …

Autoimmune or infectious diseases often instigate the undesirable damages to tissues or
organs to trigger immune-related diseases, which involve plenty of immune cells, pathogens …

Current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines, based
on the ancestral Wuhan strain, were developed rapidly to meet the needs of a devastating …

Background Age-related comorbidities such as chronic obstructive pulmonary disease
(COPD) are common in people living with human immunodeficiency virus (PLWH). We …

Immune non-responder after highly active antiretroviral therapy (HAART) is the main cause
of opportunistic infections and high mortality in AIDS patients, but the mechanism underlying …

Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in
HIV patients, as VL/HIV co-infected patients suffer from frequent VL relapse. Here, we follow …

Background Isoniazid preventive therapy (IPT) can prevent tuberculosis among people
receiving antiretroviral therapy (ART). HIV programmes are now initiating patients on ART …

Little is known about the incidence, clinical characteristics and prognostic factors in HIV
associated lymphoma as these are less common than HIV‐negative lymphoma in China …